ALAN’s abstract submitted and accepted for ASH

Earlier this year, ALAN submitted an abstract ” Understanding Relapsed/Refractory Acute Leukemia Patients Treatment Preferences: Insights from Qualitative Research, ” for the 65th annual meeting and exposition of American Society of Hematology (ASH) to be held from December, 9th to 12th 2023.

The abstract has been selected by ASH Program Committee for a poster presentation during the congress.

Here are our presentation details:

Session Name: 903. Health Services and Quality Improvement –Myeloid Malignancies: Poster II
Session Date: Sunday, December 10, 2023
Presentation Time: 6:00 PM – 8:00 PM
Location: San Diego Convention Center, Halls G-H

Publication Number: 3730
Title: Understanding Relapsed/Refractory Acute Leukemia Patients Treatment Preferences: Insights from Qualitative Research

Link to the abstract: https://doi.org/10.1182/blood-2023-172871

We have another abstract which was submitted

Title: A Study to Demonstrate Impact of Active Referral of Acute Leukemia Patients and Families to Patient Organization at Diagnosis

Link to the abstract: https://doi.org/10.1182/blood-2023-173421